Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pao Group Inc (PAOG)

Pao Group Inc (PAOG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PAOG with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0055 +76.36%
on 03/25/21
0.0100 -3.00%
on 04/12/21
+0.0006 (+6.59%)
since 03/12/21
3-Month
0.0030 +223.33%
on 01/20/21
0.0200 -51.50%
on 02/09/21
+0.0064 (+193.94%)
since 01/12/21
52-Week
0.0003 +3,133.33%
on 07/10/20
0.0200 -51.50%
on 02/09/21
+0.0093 (+2,325.00%)
since 04/09/20

Most Recent Stories

More News
PURA Announces Management Update Next Week To Highlight Latest ALKM Equity Partnership Progress and Farmersville Plans With PAOG and USMJ

, /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today announced a management update scheduled , 2021 to follow the upcoming FY2021 Annual Report coming later this week.

PURA : 0.0220 (+3.29%)
ALKM : 0.0031 (-11.43%)
PAOG : 0.0097 (+21.25%)
USMJ : 0.0014 (-6.67%)
PURA Schedules Update To Follow Upcoming Annual RPT Highlighting Increasing Interest In ALKM, Breaking Ground in Farmersville, And PAOG and USMJ Partnerships

Dallas, Texas--(Newsfile Corp. - April 12, 2021) - Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20, 2021 to follow the upcoming FY2021 Annual Report coming later...

PURA : 0.0220 (+3.29%)
PAOG : 0.0097 (+21.25%)
USMJ : 0.0014 (-6.67%)
ALKM : 0.0031 (-11.43%)
PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021

, /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on .

PAOG : 0.0097 (+21.25%)
KALY : 0.0017 (-5.56%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)
PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

Sandusky, Ohio--(Newsfile Corp. - April 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the Company's ongoing CBD Pharmaceutical Development Program progress scheduled...

PAOG : 0.0097 (+21.25%)
KALY : 0.0017 (-5.56%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)
PAOG Advances CBD Pharmaceutical Developments Backed By US Patent

Sandusky, Ohio--(Newsfile Corp. - April 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled...

PAOG : 0.0097 (+21.25%)
KALY : 0.0017 (-5.56%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)
PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

, /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on .

PAOG : 0.0097 (+21.25%)
KALY : 0.0017 (-5.56%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)
PAOG Targets September 2021 to Introduce CBD Nutraceuticals to Market Co-Packed by ALKM and Marketed Through USMJ

Sandusky, Ohio--(Newsfile Corp. - March 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released details on the Company's nutraceutical developments initiative following last week's introduction of...

PAOG : 0.0097 (+21.25%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)
KALY : 0.0017 (-5.56%)
PURA and PAOG Expand Cannabis Partnership

, /PRNewswire/ -- Puration, Inc. (USOTC: PURA) and PAOG Group, Inc. (USOTC: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through...

PURA : 0.0220 (+3.29%)
PAOG : 0.0097 (+21.25%)
USMJ : 0.0014 (-6.67%)
ALKM : 0.0031 (-11.43%)
PURA and PAOG Confirm Ongoing and Expanding Cannabis Partnership

Dallas, Texas--(Newsfile Corp. - March 11, 2021) - Puration, Inc. (OTC Pink: PURA) and PAOG Group, Inc. (OTC Pink: PAOG) today confirmed the two companies continue to work together on developing a variety...

PURA : 0.0220 (+3.29%)
PAOG : 0.0097 (+21.25%)
USMJ : 0.0014 (-6.67%)
ALKM : 0.0031 (-11.43%)
PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update

Sandusky, Ohio--(Newsfile Corp. - March 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to , when PAOG will publish details on the company's CBD RELAX-RX nutraceutical development...

PAOG : 0.0097 (+21.25%)
KALY : 0.0017 (-5.56%)
ALKM : 0.0031 (-11.43%)
USMJ : 0.0014 (-6.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.0127
2nd Resistance Point 0.0114
1st Resistance Point 0.0105
Last Price 0.0097
1st Support Level 0.0083
2nd Support Level 0.0070
3rd Support Level 0.0061

See More

52-Week High 0.0200
Fibonacci 61.8% 0.0125
Fibonacci 50% 0.0101
Last Price 0.0097
Fibonacci 38.2% 0.0078
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar